Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
October 21, 2003
Perlecan and tumor angiogenesis
Xinnong Jiang, John R Couchman
Oncology Letters
|
April 27, 2026
Soluble isoforms of EGFR family in breast cancer: Advances and clinical relevance (Review)
Peng Yang, Xinnong Jiang, Fangguo He
The Journal of Biological Chemistry
|
March 17, 2010
Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits
Xinnong Jiang, Sen Chen, John M Asara, et al.
International Immunopharmacology
|
December 31, 2024
Targeting the tumor immune microenvironment: GPCRs as key regulators in triple-negative breast cancer
Chengyi Wang, Yanyan Liu, Ru Zhang, et al.
Cancer Research
|
June 4, 2009
Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2
Changmeng Cai, David C Portnoy, Hongyun Wang, et al.
Database : the Journal of Biological Databases and Curation
|
April 25, 2018
StraPep: a structure database of bioactive peptides
Jian Wang, Tailang Yin, Xuwen Xiao, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
November 24, 2004
Essential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesis
Xinnong Jiang, Hinke Multhaupt, En Chan, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
January 24, 2012
GABAB receptor complex as a potential target for tumor therapy
Xinnong Jiang, Li Su, Qian Zhang, et al.
Discover Oncology
|
July 3, 2024
Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives
Jianzhong Liu, Shuai Xia, Baoyi Zhang, et al.
Molecular Pharmacology
|
April 21, 2017
GABA<sub>B</sub>R-Induced EGFR Transactivation Promotes Migration of Human Prostate Cancer Cells
Shuai Xia, Cong He, Yini Zhu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
October 21, 2003
Perlecan and tumor angiogenesis
Xinnong Jiang, John R Couchman
Oncology Letters
|
April 27, 2026
Soluble isoforms of EGFR family in breast cancer: Advances and clinical relevance (Review)
Peng Yang, Xinnong Jiang, Fangguo He
The Journal of Biological Chemistry
|
March 17, 2010
Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits
Xinnong Jiang, Sen Chen, John M Asara, et al.
International Immunopharmacology
|
December 31, 2024
Targeting the tumor immune microenvironment: GPCRs as key regulators in triple-negative breast cancer
Chengyi Wang, Yanyan Liu, Ru Zhang, et al.
Cancer Research
|
June 4, 2009
Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2
Changmeng Cai, David C Portnoy, Hongyun Wang, et al.
Database : the Journal of Biological Databases and Curation
|
April 25, 2018
StraPep: a structure database of bioactive peptides
Jian Wang, Tailang Yin, Xuwen Xiao, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
November 24, 2004
Essential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesis
Xinnong Jiang, Hinke Multhaupt, En Chan, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
January 24, 2012
GABAB receptor complex as a potential target for tumor therapy
Xinnong Jiang, Li Su, Qian Zhang, et al.
Discover Oncology
|
July 3, 2024
Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives
Jianzhong Liu, Shuai Xia, Baoyi Zhang, et al.
Molecular Pharmacology
|
April 21, 2017
GABA<sub>B</sub>R-Induced EGFR Transactivation Promotes Migration of Human Prostate Cancer Cells
Shuai Xia, Cong He, Yini Zhu, et al.
Page
of 2